CA1170598A - Process for the preparation of cyclic peptide nuclei - Google Patents

Process for the preparation of cyclic peptide nuclei

Info

Publication number
CA1170598A
CA1170598A CA000365986A CA365986A CA1170598A CA 1170598 A CA1170598 A CA 1170598A CA 000365986 A CA000365986 A CA 000365986A CA 365986 A CA365986 A CA 365986A CA 1170598 A CA1170598 A CA 1170598A
Authority
CA
Canada
Prior art keywords
nucleus
formula
factor
antibiotic
nrrl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000365986A
Other languages
English (en)
French (fr)
Inventor
Bernard J. Abbott
David S. Fukuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/181,036 external-priority patent/US4304716A/en
Priority claimed from US06/181,449 external-priority patent/US4299762A/en
Priority claimed from US06/181,443 external-priority patent/US4293490A/en
Priority claimed from US06/181,437 external-priority patent/US4299763A/en
Priority claimed from US06/181,029 external-priority patent/US4293482A/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of CA1170598A publication Critical patent/CA1170598A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/62—Streptosporangium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA000365986A 1979-12-13 1980-12-02 Process for the preparation of cyclic peptide nuclei Expired CA1170598A (en)

Applications Claiming Priority (20)

Application Number Priority Date Filing Date Title
US10301779A 1979-12-13 1979-12-13
US10301679A 1979-12-13 1979-12-13
US10326879A 1979-12-13 1979-12-13
US10331379A 1979-12-13 1979-12-13
US10312179A 1979-12-13 1979-12-13
US103,268 1979-12-13
US103,017 1979-12-13
US103,016 1979-12-13
US103,121 1979-12-13
US181,036 1980-08-25
US06/181,036 US4304716A (en) 1979-12-13 1980-08-25 S 31794/F-1 Nucleus
US06/181,449 US4299762A (en) 1979-12-13 1980-08-25 A-30912D Nucleus
US181,437 1980-08-25
US06/181,443 US4293490A (en) 1979-12-13 1980-08-25 A-30912H Nuclei
US06/181,437 US4299763A (en) 1979-12-13 1980-08-25 A-30912B Nucleus
US181,029 1980-08-25
US06/181,029 US4293482A (en) 1979-12-13 1980-08-25 A-30912A Nucleus
US181,449 1980-08-25
US103,313 1987-10-01
US181,443 1988-04-14

Publications (1)

Publication Number Publication Date
CA1170598A true CA1170598A (en) 1984-07-10

Family

ID=27580999

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000365986A Expired CA1170598A (en) 1979-12-13 1980-12-02 Process for the preparation of cyclic peptide nuclei

Country Status (17)

Country Link
EP (1) EP0031221B1 (enExample)
JP (1) JPS6425797A (enExample)
KR (1) KR840000769B1 (enExample)
CA (1) CA1170598A (enExample)
CH (1) CH646701A5 (enExample)
DD (1) DD155250A5 (enExample)
DE (1) DE3062235D1 (enExample)
DK (1) DK528680A (enExample)
FI (1) FI803872A7 (enExample)
FR (1) FR2484451B1 (enExample)
GB (1) GB2065131B (enExample)
GR (1) GR72254B (enExample)
IL (1) IL61651A (enExample)
IT (1) IT1141151B (enExample)
PL (1) PL228450A1 (enExample)
PT (1) PT72153B (enExample)
YU (1) YU311080A (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982000587A1 (en) * 1980-08-15 1982-03-04 Tscherter H New metabolites,processes for their production and their use
US4322406A (en) * 1980-12-18 1982-03-30 Eli Lilly And Company Antibiotic A-4696 factors B1, B2, B3, C1a, C3 and E1
IL64486A (en) * 1980-12-18 1985-01-31 Lilly Co Eli Antibiotic a-4696 factor g,its preparation and use as feed supplement for ruminant animals
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
US4587218A (en) * 1983-10-21 1986-05-06 Eli Lilly And Company Novel bioconverting microorganisms
CA2037957A1 (en) * 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
IL145188A0 (en) 1999-03-03 2002-06-30 Lilly Co Eli Processes for making pharmaceutical oral ecb formulations and compositions
DK1582204T3 (da) 1999-03-03 2013-11-04 Lilly Co Eli Echinocandin-farmaceutiske formuleringer, der indeholder miceldannende overfladeaktive stoffer
DK1157030T3 (da) 1999-03-03 2003-12-22 Lilly Co Eli Enchinocanidin/carbohydratkomplekser
JP4063497B2 (ja) 1999-03-03 2008-03-19 イーライ リリー アンド カンパニー エキノカンジンアンモニウム塩結晶の形成およびアニオン交換
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
CN102618606B (zh) * 2011-01-30 2014-09-10 浙江海正药业股份有限公司 一种棘白菌素生物转化方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3150059A (en) * 1962-12-26 1964-09-22 Lilly Co Eli Penicillin deacylation via actinoplanaceae fermentation
JPS5134916B2 (enExample) * 1974-03-06 1976-09-29
ES449582A1 (es) * 1975-07-08 1977-12-01 Sandoz Ag Procedimiento para la produccion de s 31794nf-1.
IE43663B1 (en) * 1975-10-02 1981-04-22 Lilly Co Eli Antibiotic and process for production thereof
US4024245A (en) * 1975-10-02 1977-05-17 Eli Lilly And Company Antibiotic A-30912 and process for production thereof
GR61684B (en) * 1975-10-02 1978-12-09 Lilly Co Eli Preparation process of antibiotic a-22082
US4024246A (en) * 1975-10-02 1977-05-17 Eli Lilly And Company Antibiotic A-22082 and process for production thereof
DE2704030A1 (de) * 1976-02-12 1977-08-18 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
DE2742435A1 (de) * 1976-09-28 1978-04-06 Sandoz Ag Aminoalkylaether der peptide tetrahydro- sl 7810/f-ii, s 31794/f-1, aculeacin a und tetrahydroechinocandin b, ihre verwendung und herstellung
DE2803584A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Aminoalkylaether der peptide tetrahydro-sl 7810/f-ii, s 31794/f-1, aculeacin a und tetrahydroechinocandin b, ihre verwendung und herstellung
DE2803581A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Derivate des tetrahydro-echinocandin b
BE883593A (fr) * 1979-06-08 1980-12-02 Lilly Co Eli Nouveaux antibiotiques, leur preparation et leur utilisation therapeutique

Also Published As

Publication number Publication date
DE3062235D1 (de) 1983-04-07
FR2484451A1 (fr) 1981-12-18
FI803872L (fi) 1981-06-14
GB2065131B (en) 1983-06-22
CH646701A5 (fr) 1984-12-14
KR840000769B1 (ko) 1984-06-08
PT72153B (en) 1981-10-28
IT1141151B (it) 1986-10-01
FR2484451B1 (fr) 1985-12-06
YU311080A (en) 1983-02-28
GB2065131A (en) 1981-06-24
KR830004215A (ko) 1983-07-06
JPH0353320B2 (enExample) 1991-08-14
IT8026634A0 (it) 1980-12-12
FI803872A7 (fi) 1981-06-14
PT72153A (en) 1981-01-01
EP0031221B1 (en) 1983-03-02
JPS6425797A (en) 1989-01-27
IL61651A (en) 1984-04-30
PL228450A1 (enExample) 1981-08-07
EP0031221A1 (en) 1981-07-01
GR72254B (enExample) 1983-10-06
IL61651A0 (en) 1981-01-30
DK528680A (da) 1981-06-14
DD155250A5 (de) 1982-05-26

Similar Documents

Publication Publication Date Title
US4293482A (en) A-30912A Nucleus
US4293489A (en) Derivatives of A-30912A nucleus
US4287120A (en) Derivatives of S31794/F-1 nucleus
EP0359529B1 (en) Method for the control of pneumocystis carinii
CA1170598A (en) Process for the preparation of cyclic peptide nuclei
US4320052A (en) Derivatives of A-30912A nucleus
US4320053A (en) Derivatives of A-30912D nucleus
US4322338A (en) Derivatives of A-30912B nucleus
US4304716A (en) S 31794/F-1 Nucleus
US4320054A (en) Derivatives of A-30912H nucleus
CA1183127A (en) Process for the preparation of derivatives of cyclic peptide nuclei
CA1182812A (en) Process for the preparation of derivatives of cyclic peptide nuclei
US4208403A (en) A-21978 Antibiotics and process for their production
US4299763A (en) A-30912B Nucleus
USRE32333E (en) A-21978 Antibiotics and process for their production
US4293488A (en) Derivatives of A-30912B nucleus
US4293485A (en) Derivatives of S31794/F-1 nucleus
US4293491A (en) Derivatives of A-30912H nucleus
US4293490A (en) A-30912H Nuclei
EP0095295B1 (en) Cyclic peptide derivatives
US4293483A (en) Derivatives of A-30912A nucleus
CA1156218A (en) Antibiotic a-30912 factor h
US4293487A (en) Derivatives of A-30912D nucleus
US4299762A (en) A-30912D Nucleus
CA1159450A (en) Process for the preparation of derivatives of cyclic peptide nuclei

Legal Events

Date Code Title Description
MKEX Expiry